Disruption of P2Y2 signaling promotes breast tumor cell dissemination by reducing ATP-dependent calcium elevation and actin localization to cell junctions

Makenzy L Mull,Stephen J P Pratt,Keyata N Thompson,David A Annis,Abanoub A Gad,Rachel M Lee,Katarina T Chang,Megan B Stemberger,Julia A Ju,Darin E Gilchrist,Liron Boyman,Michele I Vitolo,W Jonathan Lederer,Stuart S Martin
DOI: https://doi.org/10.1101/2023.03.31.533191
2024-06-13
Abstract:The tumor microenvironment and wound healing after injury both contain extremely high concentrations of the extracellular signaling molecule, adenosine triphosphate (ATP) compared to normal tissue. P2Y2 receptor, an ATP-activated purinergic receptor, is typically associated with pulmonary, endothelial, and neurological cell signaling. Here we report its role and importance in breast epithelial cell signaling and how it is altered in metastatic breast cancer. In response to ATP activation, P2Y2 receptor signaling causes an increase of intracellular Ca2+ in non-tumorigenic breast epithelial cells, while their tumorigenic and metastatic counterparts have significantly reduced Ca2+ responses. The non-tumorigenic cells respond to increased Ca2+ with actin polymerization and localization to cell edges, while the metastatic cells remained unaffected. The increase in intracellular Ca2+ after ATP stimulation was blunted using a P2Y2 antagonist, which also prevented actin mobilization and caused cell dissemination from spheroids in non-tumorigenic breast epithelial cells. Furthermore, the lack of Ca2+ concentration changes and actin mobilization in the metastatic breast cancer cells could be due to reduced P2Y2 expression, which correlates with poorer overall survival in breast cancer patients. This study elucidates rapid changes that occur after elevated intracellular Ca2+ in breast epithelial cells and how metastatic cancer cells have adapted to evade this cellular response.
Cancer Biology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore the mechanism of action of the P2Y2 receptor in the spread of breast tumor cells. Specifically, the study focused on how the P2Y2 receptor signaling pathway affects the increase in intracellular calcium ion concentration and the localization of actin at cell junctions, and how these changes differ between non - malignant breast epithelial cells and malignant metastatic breast cancer cells. ### Background and Core of the Problem 1. **High Concentration of Extracellular ATP**: In the tumor microenvironment (TME) and during the wound - healing process, the concentration of extracellular ATP is significantly higher than that in normal tissues. This high - concentration ATP can activate the P2Y2 receptor, thereby affecting intracellular signal transduction. 2. **Role of the P2Y2 Receptor**: The P2Y2 receptor is usually related to signal transduction in lung, endothelial, and nerve cells. However, its role in breast epithelial cells and its changes in metastatic breast cancer have not been fully elucidated. 3. **Changes in Intracellular Calcium Ions**: After activation by ATP, the intracellular calcium ion concentration in non - malignant breast epithelial cells will increase significantly, while the response of malignant metastatic breast cancer cells to ATP is weaker. 4. **Relocalization of Actin**: After the increase in calcium ion concentration, actin will aggregate and localize at the cell edge in non - malignant cells, while malignant cells do not have this response. 5. **Reduction in P2Y2 Receptor Expression**: The study found that the expression of the P2Y2 receptor in malignant metastatic breast cancer cells is reduced, which may lead to their weakened response to ATP and is associated with poor prognosis in patients. ### Research Objectives - **To elucidate the signal transduction mechanism of the P2Y2 receptor in non - malignant breast epithelial cells**: By observing the changes in intracellular calcium ion concentration and the relocalization of actin after ATP activation, understand how normal cells respond to ATP signals. - **To explore the changes in P2Y2 receptor signal transduction in malignant metastatic breast cancer cells**: Analyze why these cells have a weakened response to ATP and the impact of this change on cell behavior. - **To evaluate the possibility of the P2Y2 receptor as a potential therapeutic target**: By inhibiting the P2Y2 receptor, observe its different effects on non - malignant and malignant cells, thereby exploring the potential of the P2Y2 receptor in breast cancer treatment. ### Conclusion The study found that the disruption of the P2Y2 receptor signaling pathway will lead to the spread of breast tumor cells, mainly by reducing ATP - dependent calcium ion elevation and the localization of actin at cell junctions. This finding provides important clues for further research on the role of the P2Y2 receptor in breast cancer and may provide a theoretical basis for the development of new treatment strategies.